ENTITY

Tempus AI (TEM US)

Analysis

Health Care • United States

Tempus AI, Inc. operates as a clinical laboratory. The Company provides genomic sequencing services and analyze molecular and therapeutic data to help physicians to make real-time and data-driven decisions.Tempus AI serves customers in the United States.

Refresh

Exchange Announcement • 18 Jun 2024 04:34

S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Exchange Announcement • 18 Jun 2024 04:05

Current Report (Form 8-K | Period ending 2024-06-17)

Exchange Announcement • 17 Jun 2024 18:07

424B4 | Prospectus

Exchange Announcement • 13 Jun 2024 18:26

S-1/A | IPO Registration (Amendment)

No more filings

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00